BALAXI PHARMACEUTICALS LIMITED has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
BALAXI · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Balaxi Pharmaceuticals has informed the stock exchange that the trading window for its securities will be closed for all designated persons and their immediate relatives starting April 1, 2026. The window will reopen 48 hours after the company declares its audited financial results for the fourth quarter and financial year ending March 31, 2026. This closure is a routine compliance requirement under SEBI's Insider Trading Regulations, 2015. The exact date of the board meeting to consider the Q4 and FY26 audited results has not yet been announced and will be communicated later.
This is a routine regulatory compliance filing and does not directly impact shareholders. However, it signals that the company's Q4 and FY26 audited earnings are expected to be announced in the near future, which could be a relevant catalyst for the stock.